Dr Joseph Doyle

Research Field: Infectious Diseases and Public Health

In Australia, approximately 155,000 people are estimated to live with hepatitis C. With access to improved treatments and medical care, it has become possible for Australia to become one of the first countries to eliminate hepatitis C as a public health threat.

Dr Doyle’s clinical and public health research brings together the tools to eliminate hepatitis C by simplifying treatment pathways to ensure treatment is accessed by vulnerable populations. Joseph’s public outreach includes extensive media interviews, public outreach events, and through serving on advisory boards for State and Commonwealth Governments.

Dr Doyle completed his PhD at Monash University in 2014, and is currently a Deputy Director at the Burnet Institute and a Senior Lecturer at Monash University.